GRTX   $0.1463  -31.99% Market Closed

Galera Therapeutics Inc
Total Cash 10.75M
totalCashPerShare 0.198
EBITDA -24.81M
Total Debt 152.24M
quickRatio 5.056
currentRatio 5.627
Total Revenue
debtToEquity
Revenue/Share
ROA -0.48424998
ROE
grossProfits
freeCashflow -22.48M
operatingCashflow -29.94M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 145.25M
forwardPE
floatShares 39.94M
sharesOutstanding 54.39M
sharesShort 2.12M
sharesShortPriorMonth 2.66M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.32%
heldPercentInstitutions 0.01%
Short Ratio help_outline 1.16%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue -2.538
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -29.11M
trailingEps -0.51%
forwardEps -1.24%
enterpriseToEbitda -5.86
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2023
institutionsCount 3
lastUpdated Oct. 16, 2024, 8:18 p.m.